1. Home
  2. LEXX vs AMST Comparison

LEXX vs AMST Comparison

Compare LEXX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • AMST
  • Stock Information
  • Founded
  • LEXX 2004
  • AMST 2017
  • Country
  • LEXX Canada
  • AMST United States
  • Employees
  • LEXX N/A
  • AMST N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • LEXX Health Care
  • AMST Technology
  • Exchange
  • LEXX Nasdaq
  • AMST Nasdaq
  • Market Cap
  • LEXX 16.5M
  • AMST 13.3M
  • IPO Year
  • LEXX N/A
  • AMST 2020
  • Fundamental
  • Price
  • LEXX $0.82
  • AMST $2.83
  • Analyst Decision
  • LEXX Strong Buy
  • AMST
  • Analyst Count
  • LEXX 1
  • AMST 0
  • Target Price
  • LEXX $4.00
  • AMST N/A
  • AVG Volume (30 Days)
  • LEXX 200.1K
  • AMST 45.4K
  • Earning Date
  • LEXX 07-14-2025
  • AMST 09-29-2025
  • Dividend Yield
  • LEXX N/A
  • AMST N/A
  • EPS Growth
  • LEXX N/A
  • AMST N/A
  • EPS
  • LEXX N/A
  • AMST N/A
  • Revenue
  • LEXX $615,923.00
  • AMST $82,544.00
  • Revenue This Year
  • LEXX $38.85
  • AMST N/A
  • Revenue Next Year
  • LEXX $24.13
  • AMST N/A
  • P/E Ratio
  • LEXX N/A
  • AMST N/A
  • Revenue Growth
  • LEXX 49.85
  • AMST N/A
  • 52 Week Low
  • LEXX $0.78
  • AMST $2.00
  • 52 Week High
  • LEXX $4.38
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 39.23
  • AMST 41.47
  • Support Level
  • LEXX $0.82
  • AMST $2.78
  • Resistance Level
  • LEXX $0.86
  • AMST $3.02
  • Average True Range (ATR)
  • LEXX 0.07
  • AMST 0.17
  • MACD
  • LEXX -0.01
  • AMST -0.04
  • Stochastic Oscillator
  • LEXX 15.85
  • AMST 13.85

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: